Table 2. Basal cell carcinoma with myoepithelial features: immunohistochemical features.
C a s e | B e r | C a l | C E A | D e s | E M A | G F A P | K e r | p 6 3 | S 1 0 0 | S M A | S M M | S o x | V i m | R e f |
1 | NS | NS | - | - | NS | + | + | NS | + | + | NS | NS | + | [1] C1 |
2 | NS | NS | - | NS | - | NS | + | NS | - | + | NS | NS | - | [2] C12 |
3 | NS | NS | - | - | NS | + | + | NS | + | + | NS | NS | + | [1] C3 |
4 | NS | NS | NS | NS | NS | NS | + | NS | NS | - | - | NS | - | [3] |
5 | NS | NS | - | - | NS | + | + | NS | + | + | NS | NS | + | [1] C2 |
6 | NS | NS | - | NS | + | + | + | NS | + | + | NS | NS | NS | [4] |
7 | NS | NS | - | NS | - | - | + | NS | - | - | NS | NS | - | [2] C9 |
8 | + | NS | NS | NS | NS | NS | NS | NS | NS | + | NS | - | NS | CR |
9 | NS | + | NS | NS | + | NS | + | + | - | + | NS | NS | NS | [5] |
10 | + | + | - | - | - | - | + | + | + | + | NS | NS | + | [6] |
11 | NS | NS | NS | NS | NS | NS | + | NS | NS | NS | NS | NS | NS | [7] |
12 | NS | NS | NS | NS | NS | NS | + | NS | NS | + | NS | NS | - | [8] |
13 | NS | NS | - | - | NS | + | + | NS | + | + | NS | NS | + | [1] C4 |
14 | NS | NS | - | - | NS | + | + | NS | + | + | NS | NS | + | [1] C5 |
15 | NS | NS | NS | NS | NS | NS | + | NS | - | - | + | NS | + | [9] |
16 | NS | + | NS | NS | NS | NS | + | + | + | + | NS | NS | NS | [10] |
Tot | 2/2 | 3/3 | 0/9 | 0/6 | 2/5 | 6/8 | 15/15 | 3/3 | 8/12 | 13/15 | 1/2 | 0/1 | 7/11 |